drugset / Trial / NCT04253132
Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 12-week study of oral tolfenamic acid vs. placebo in Progressive Supranuclear Palsy (PSP)
Timeline
- Start
- 2021-01-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tolfenamic Acid | Small molecule | 50 mg | Oral |
| Comparator | Tolfenamic Acid | Small molecule | 300 mg | Oral |
| Comparator | Tolfenamic Acid | Small molecule | 600 mg | Oral |